Cullinan Oncology Inc. (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
8.75
0.14 (1.63%)
At close: Jun 16, 2025, 3:59 PM
8.74
-0.13%
After-hours: Jun 16, 2025, 04:04 PM EDT
1.63% (1D)
| Bid | 8.45 |
| Market Cap | 516.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -178.74M |
| EPS (ttm) | -2.77 |
| PE Ratio (ttm) | -3.16 |
| Forward PE | -2.87 |
| Analyst | Buy |
| Ask | 9 |
| Volume | 211,630 |
| Avg. Volume (20D) | 438,698 |
| Open | 8.68 |
| Previous Close | 8.61 |
| Day's Range | 8.50 - 8.78 |
| 52-Week Range | 6.85 - 21.01 |
| Beta | -0.04 |
About CGEM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
8 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.
